Kenneth Sokoll

Title: Kenneth Sokoll: Innovator in Angiogenesis

Introduction

Kenneth Sokoll is a notable inventor based in Manotick Place, Canada. He has made significant contributions to the field of biomedical innovation, particularly in the area of angiogenesis. His work focuses on developing compounds that promote wound healing and enhance tissue regeneration.

Latest Patents

Kenneth Sokoll holds a patent for an "Agent for promoting angiogenesis and methods and uses thereof." This patent describes compounds of Formula (I), which are multimeric forms of a monomeric binding peptide linearly bonded to PEG moieties to form the multimers. These multimeric forms are designed to stimulate angiogenesis and promote wound healing. The patent also includes pharmaceutical compositions comprising the multimers, suitable for both topical and systemic administration. He has 1 patent to his name.

Career Highlights

Throughout his career, Kenneth has worked with various organizations that focus on medical research and innovation. Notably, he has been associated with Vasomune Therapeutics Inc. and Sunnybrook Research Institute. His work in these institutions has contributed to advancements in therapeutic strategies for enhancing angiogenesis.

Collaborations

Kenneth has collaborated with several professionals in his field, including Daniel J Dumont and Paul Van Slyke. These collaborations have further enriched his research and development efforts.

Conclusion

Kenneth Sokoll's innovative work in promoting angiogenesis has the potential to significantly impact wound healing therapies. His contributions to the field are noteworthy, and his patent reflects his commitment to advancing medical science.